Sunday 5 April 2020
Home      All news      Contact us      India
business-standard - 11 days ago

Cipla gains on USFDA approval for Nexium generic

Cipla rose 1.88% to Rs 383.80 after the company said it received US drug regulator s final approval for generic version of AstraZeneca Pharmaceutical s Nexium.


Latest News
Hashtags:   

Cipla

 | 

gains

 | 

USFDA

 | 

approval

 | 

Nexium

 | 

generic

 | 
Most Popular (6 hours)

Most Popular (24 hours)

Most Popular (a week)

Sources